worldUpdated: Sep 12, 2020 22:38 ISTOxford University — one of the leading Covid-19 vaccine developers in the global race — resumed its trial for testing the drug it is developing with pharmaceutical company AstraZeneca on Saturday. The vaccine being developed by Oxford and AstraZeneca is widely perceived to be one of the strongest contenders among the dozens of coronavirus vaccines in various stages of testing around the world. Additionally experts believe Oxford prioritised safety protocol by pausing the trial in case of reported side-effects, showcasing responsible decision-making in such critical times. Global organization WHO and scientists have asked to keep expectations to a minimum, stating that vaccine trials are rarely straightforward and can take a tediously long time to be developed. By when is Oxford-AstraZeneca’s Covid-19 vaccine expected?

Source: Hindustan Times September 12, 2020 17:08 UTC